Grady Harrison Hofmann

Grady Harrison Hofmann

Auto-generated profile, based on publicly available information

Grady Harrison Hofmann

Stanford University School of Medicine, Department of Orthopaedic Surgery, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Allergy
Verified
Journal Article
Closed access
NCNicolas Castaño
Nicolas Castaño
KCKaiser Chua
Kaiser Chua
AKAbhinav Kaushik
Abhinav Kaushik
SKSungu Kim
Sungu Kim
SCSeth C. Cordts
Seth C. Cordts
STSindy Tang
Sindy Tang

24 September 2025 in Journal of ISAKOS
Verified
Journal Article
Open access
GHGrady H. Hofmann
Grady H. Hofmann
RSReem Sarsour
Reem Sarsour
WDWillemijn van Deursen
Willemijn van Deursen
AAAmin Alayleh
Amin Alayleh
NDNneoma Duru
Nneoma Duru
KSKevin Shea
Kevin Shea
Allograft transplants are commonly used in orthopedics. Unlike other transplanted tissues, orthopedic tissue allografts are not human leukocyte antigen (HLA)-matched. The clinical impact of the immune response to allografts is poorly understood. Recent experience with allograft failures and reactions to anterior cruciate ligaments (ACL), medial patellofemoral ligament (MPFL), osteochondral, and meniscus transplants raises concern. This scoping review examines the literature on immunologic rejection of orthopedic tissue allograft using PubMed, Embase, Web of Science, and Scopus for studies describing immune rejection of orthopedic tissue allografts in humans and animals. Four reviewers independently screened titles/abstracts based on these criteria. Full texts were screened independently by two reviewers for inclusion. Variables of interest included the species, graft type, and graft treatment. Our literature search yielded 1625 articles, with 78 meeting the inclusion criteria. Of these studies, 30 (38.5%) were in humans, 16 (20.5%) in rats, and 11 (14.1%) in dogs. The remaining 21 studies were in a combination of rabbit, primate, mice, sheep, and cat subjects. The orthopedic tissues in these studies included 23 osteochondral (29.5%), 16 bone (20.5%), 13 cartilage (16.7%), 6 bone-tendon-bone (7.7%), and 12 tendon/ligaments (15.4%) with 8 (10.2%) of the studies specifically in menisci. Methods used to reduce immune response include freezing, irrigation, and immunosuppressant administration. Recorded histological evidence of immune response included cell apoptosis, type II collagen increase, interleukins (IL) secretion, and increased lymphocytes/plasma cells in the synovial fluid. The pathways proposed were mismatched in cell-surface proteins as many studies conducted major histocompatibility complex (MHC) class I matching, which reduced the immune response. Despite histological evidence, including HLA sensitization after transplant signaling an immune response, clinical significance was not observed. Recent clinical experience of increased magnetic resonance imaging (MRI) signal response to orthopedic allografts, along with patient symptoms, has raised questions about rejection. Clinical rejection reports are limited in this review. This immune response to orthopedic allografts must be considered, and additional studies are needed to explore the relationship between rejection and clinical outcomes. This scoping review indicates that there is a range of human and animal studies demonstrating various immunologic response presentations and severities with different orthopedic tissue allografts.

21 January 2026 in HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery
Verified
Journal Article
Closed access
GSGabriella B. Smith
Gabriella B. Smith
GHGrady H. Hofmann
Grady H. Hofmann
AGAnna V. Gussner
Anna V. Gussner
NDNneoma O. Duru
Nneoma O. Duru
TLTara A. Laureano
Tara A. Laureano
KSKevin G. Shea
Kevin G. Shea
Background: Avascular necrosis (AVN) of the bone may result in severe pain, and patients with AVN and their families may seek out information about the condition. With the rise of ChatGPT, AVN patients and families may turn to this chatbot with questions. Purpose: We sought to explore expert clinicians’ perceptions of the quality of ChatGPT’s responses to frequently asked parent questions about AVN in children. Secondary aims of this study were to assess provider perceptions of ChatGPT and AVN parental education and to evaluate the readability of ChatGPT responses. Methods: We conducted a cross-sectional survey study of 9 pediatric orthopedic surgeons, oncologists, and advanced practice providers with expertise in the clinical management of AVN. Fifteen common questions parents ask about AVN were posed to ChatGPT, preceded by the following prompt: “Please answer the following parent question relating to avascular necrosis. Please give me a response at or below a sixth-grade reading level: [Question].” The answers were evaluated by participants using a 4-point Likert scale. ChatGPT responses were also assessed using the following readability scores: Flesch-Kincaid Grade Level, Gunning Fog index, and Flesch Reading Ease. In addition, the survey included 4 questions developed to gather overall provider perceptions. Results: Providers deemed answers to all 15 questions as at least satisfactory, requiring minimal clarification on average. Yet only 3 ChatGPT responses (20%) were at or below a sixth-grade reading level, as prompted. The average Flesch-Kincaid Grade Level was 6.94, and the average Gunning Fog Index was 9.22, suggesting the responses reflect a reading level between approximately seventh grade and early high school. A majority of providers agreed that these responses would be sufficient for most parents (56%) and that the information was at the appropriate reading level (100%). Conclusion: The findings of this small survey study suggest that ChatGPT’s responses to common parent questions about AVN were satisfactory, requiring minimal clarification. ChatGPT has the potential to serve as a resource for orthopedic patients and family education, though concerns remain.

15 August 2025 in Transplantation and Cellular Therapy
Verified
Journal Article
Closed access
DEDavid J. Epstein
David J. Epstein
NRNidia Rodriguez-Ormaza
Nidia Rodriguez-Ormaza
HSHusham Sharifi
Husham Sharifi
YLYu Kuang Lai
Yu Kuang Lai
HGHaiwei Henry Guo
Haiwei Henry Guo
JHJoe Hsu
Joe Hsu